PTP4A3 and colorectal cancer: PRL-3 is a dual-specificity phosphatase, meaning that it can dephosphorylate both tyrosine and serine/threonine residues, and is encoded by the gene PTP4A3. PRL-3 was first described in 1998, and associated with metastatic potential in colorectal cancer [9].